Eliquis Lawsuits

Lawyers are already preparing for a large influx of Eliquis lawsuits stemming from Pfizer and Bristol- Myers Squibb’s acquisition of Xarelto. In May, the company agreed to pay up to $ 650 million to resolve close to 4,500 Pradaxa lawsuits, according to court documents. Some plaintiffs in Eliquis lawsuits filed by Bristol- Myers has already received settlements from the companies. Lawsuits against GlaxoSmithKline and Sanofi Aventis are expected to increase. If approved by a federal judge in the Eastern District of Florida, lawyers anticipate that Eliquis could be the next big payday for pharmaceutical company shareholders.

The FDA is still examining the effects of Eliquis on patients’ health.

It is unknown if the new class action drug will undergo further study or approval from the FDA. Eliquis lawsuits could involve the manufacturer, a distributor, a manufacturer’s product supplier, and retailers. Class action attorneys have been involved in cases similar to this one regarding GlaxoSmithKline’s Prilosec and Vioxx, which are currently undergoing FDA reviews.

Eliquis lawsuits may also target Pfizer, the world’s largest drug maker.

Last year, the company merged with Actonel, which held the rights to Eliquis. In June of last year, a New York federal grand jury indicted two men – one of whom worked at Actonel’s consulting division – on securities fraud charges. The company released a statement claiming that the man was not a direct employee of the company and that he only provided consulting services. It is not clear whether these two men are the only people to face charges relating to Eliquis. A lawyer for one of the men has already been fired from Actonel, while another man faces trial on December 13th.

An internal investigation conducted by the company into the manufacturing of Eliquis showed that its manufacturing lines were, in fact, incorrectly trained.

Employees were instructed to add potassium hydroxide into the medicines, but not to change them into what is known as an “active” form. This was done in an effort to make it easier for doctors to prescribe. The resulting lawsuits may result in compensation for patients who suffered respiratory distress or other injuries when taking the drugs.

One of the primary focuses of the lawsuits is on the lack of warnings about the potential risks of taking Eliquis.

Although the Food and Drug Administration has approved Eliquis for sale, there was no indication in the medicines’ labeling about the potential risks of taking the medicines. Many doctors routinely give Eliquis to patients with asthma and other conditions, without any indication of the possibility of the drugs causing severe harm. Such practices may result in substantial monetary damages for patients who purchased Eliquis with insufficient information about the risks of taking the drugs. The lawsuits will be filed by the victims of this negligence.

There are additional aspects to the lawsuits that indicate the possible risk of Eliquis.

The lawsuits further claim that the drug makers knew about the potential risks of using Eliquis. They did not take steps to mitigate those risks. Another area of potential liability is the fact that some patients, who have already been given Eliquis doses, are having difficulty breathing once their treatments are stopped. The lawsuits will seek damages for those who suffer from these symptoms. It appears that the potential liabilities of the drug makers are real, although the extent of those liabilities will vary based on the extent of negligence on the part of the manufacturer.

Leave a Reply

Your email address will not be published. Required fields are marked *